ATE396177T1 - Neue kristalline formen eines faktor xa inhibitors - Google Patents
Neue kristalline formen eines faktor xa inhibitorsInfo
- Publication number
- ATE396177T1 ATE396177T1 AT01979459T AT01979459T ATE396177T1 AT E396177 T1 ATE396177 T1 AT E396177T1 AT 01979459 T AT01979459 T AT 01979459T AT 01979459 T AT01979459 T AT 01979459T AT E396177 T1 ATE396177 T1 AT E396177T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitor
- factor
- crystalline forms
- new crystalline
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23831600P | 2000-10-05 | 2000-10-05 | |
| GBGB0108903.6A GB0108903D0 (en) | 2000-10-05 | 2001-04-10 | Novel crystalline forms of a factor Xa inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396177T1 true ATE396177T1 (de) | 2008-06-15 |
Family
ID=22897372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01979459T ATE396177T1 (de) | 2000-10-05 | 2001-10-04 | Neue kristalline formen eines faktor xa inhibitors |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7034160B2 (de) |
| EP (1) | EP1326838B1 (de) |
| JP (1) | JP4177663B2 (de) |
| AT (1) | ATE396177T1 (de) |
| AU (2) | AU1142502A (de) |
| CA (1) | CA2424565C (de) |
| CY (1) | CY1108224T1 (de) |
| DK (1) | DK1326838T3 (de) |
| ES (1) | ES2304396T3 (de) |
| GB (1) | GB0108903D0 (de) |
| IL (1) | IL155189A (de) |
| MX (1) | MXPA03002067A (de) |
| PT (1) | PT1326838E (de) |
| WO (1) | WO2002028836A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6964784B2 (en) * | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| RU2597423C2 (ru) * | 2011-03-29 | 2016-09-10 | Санофи | Бензойнокислая соль отамиксабана |
| TWI551289B (zh) * | 2011-03-29 | 2016-10-01 | 賽諾菲公司 | 具有改良之安定性之奧米沙班調配物 |
| AU2012234323A1 (en) * | 2011-03-29 | 2013-10-17 | Sanofi | Otamixaban formulations with improved stability |
| KR20190040370A (ko) | 2012-06-04 | 2019-04-17 | 파마싸이클릭스 엘엘씨 | 브루톤 타이로신 키나아제 저해제의 결정 형태 |
| JP2017523206A (ja) | 2014-08-07 | 2017-08-17 | ファーマサイクリックス エルエルシー | ブルトン型チロシンキナーゼ阻害剤の新規製剤 |
| IL315294A (en) | 2015-03-03 | 2024-10-01 | Pharmacyclics Llc | Pharmaceutical formulations of proton tyrosine kinase inhibitor |
| MA41827A (fr) * | 2015-03-27 | 2018-01-30 | Pharmacyclics Llc | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080767A (en) * | 1996-01-02 | 2000-06-27 | Aventis Pharmaceuticals Products Inc. | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| CN1273128C (zh) * | 1996-01-02 | 2006-09-06 | 阿温蒂斯药物公司 | 取代的n－[(氨基亚氨基甲基或氨基甲基)苯基]丙基酰胺 |
-
2001
- 2001-04-10 GB GBGB0108903.6A patent/GB0108903D0/en not_active Ceased
- 2001-10-04 AU AU1142502A patent/AU1142502A/xx active Pending
- 2001-10-04 CA CA2424565A patent/CA2424565C/en not_active Expired - Fee Related
- 2001-10-04 AT AT01979459T patent/ATE396177T1/de active
- 2001-10-04 JP JP2002532422A patent/JP4177663B2/ja not_active Expired - Fee Related
- 2001-10-04 PT PT01979459T patent/PT1326838E/pt unknown
- 2001-10-04 DK DK01979459T patent/DK1326838T3/da active
- 2001-10-04 WO PCT/US2001/031087 patent/WO2002028836A1/en active Application Filing
- 2001-10-04 AU AU2002211425A patent/AU2002211425B2/en not_active Ceased
- 2001-10-04 MX MXPA03002067A patent/MXPA03002067A/es active IP Right Grant
- 2001-10-04 EP EP01979459A patent/EP1326838B1/de not_active Expired - Lifetime
- 2001-10-04 ES ES01979459T patent/ES2304396T3/es not_active Expired - Lifetime
-
2003
- 2003-04-01 US US10/404,678 patent/US7034160B2/en not_active Expired - Lifetime
- 2003-04-01 IL IL155189A patent/IL155189A/en not_active IP Right Cessation
-
2008
- 2008-07-29 CY CY20081100790T patent/CY1108224T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1326838T3 (da) | 2008-09-22 |
| US20030225144A1 (en) | 2003-12-04 |
| MXPA03002067A (es) | 2003-06-24 |
| CY1108224T1 (el) | 2014-02-12 |
| WO2002028836A1 (en) | 2002-04-11 |
| JP2004521082A (ja) | 2004-07-15 |
| AU1142502A (en) | 2002-04-15 |
| PT1326838E (pt) | 2008-07-08 |
| WO2002028836A9 (en) | 2003-11-20 |
| JP4177663B2 (ja) | 2008-11-05 |
| CA2424565C (en) | 2011-04-26 |
| IL155189A (en) | 2011-11-30 |
| EP1326838A1 (de) | 2003-07-16 |
| ES2304396T3 (es) | 2008-10-16 |
| CA2424565A1 (en) | 2002-04-11 |
| US7034160B2 (en) | 2006-04-25 |
| GB0108903D0 (en) | 2001-05-30 |
| EP1326838B1 (de) | 2008-05-21 |
| AU2002211425B2 (en) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| CA2441313A1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| DE69907963D1 (de) | Heteroaromatische amide als inhibitoren von faktor xa | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| AP1744A (en) | Inhibitors of factor XA and other serine proteases involved in the coagulation cascade | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| DE60229530D1 (de) | Substituierte piperazine als modulatoren des melanocortinrezeptors | |
| DE60236102D1 (en) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
| ATE374765T1 (de) | Substituierte heterocyclische amide | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| EA200501268A1 (ru) | Ингибирующие вич 1,2,4-триазины | |
| UY27991A1 (es) | Derivados de pirrolidona domo inhibidores de maob | |
| DE50113345D1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
| CY1108224T1 (el) | Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα | |
| SE0403171D0 (sv) | New compounds | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| DE60229420D1 (de) | Neue metallproteinaseinhibitoren | |
| MXPA04002282A (es) | Nuevos compuestos y preparaciones como inhibidores de la catepsina. | |
| RS94603A (en) | Novel compounds and compositions as cathepsin inhibitors | |
| DE60114640D1 (en) | Antithrombosemittel | |
| DE60121804D1 (de) | Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin | |
| ATE501127T1 (de) | Neue cysteinproteasehemmer und ihre therapeutische anwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1326838 Country of ref document: EP |